Cargando…
Treatment of Chronic Constipation using Elobixibat in a Real-World Setting: A Retrospective Cohort Study using an Electronic Medical Records Database in Japan
BACKGROUND: Chronic constipation is a common condition affecting people of all ages; therefore, the socioeconomic burden of chronic constipation is nonnegligible. Elobixibat (ELO), an ileal bail acid transport inhibitor, was launched in Japan in 2018. However, evidence of its use in diverse populati...
Autores principales: | Masaki, Hisanori, Shimamoto, Koji, Inokuchi, Shoichiro, Ishizaki, Sonoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685011/ https://www.ncbi.nlm.nih.gov/pubmed/38033932 http://dx.doi.org/10.1016/j.curtheres.2023.100724 |
Ejemplares similares
-
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation
por: Nakajima, Atsushi, et al.
Publicado: (2022) -
Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study
por: Hishida, Yoshiaki, et al.
Publicado: (2022) -
Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study
por: Manabe, Noriaki, et al.
Publicado: (2023) -
Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
por: Kamei, Daigo, et al.
Publicado: (2020) -
The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
por: Tomie, Akira, et al.
Publicado: (2020)